Active Substance & Generic Molecule Directory

Tranexamic Acid in Malaysia: Registered Brands, Dosages & Price Comparison

Directory of all approved pharmaceutical brands containing Tranexamic Acid registered with the National Pharmaceutical Regulatory Agency (NPRA) / Ministry of Health Malaysia (KKM).

12
Registered Brands
Availability in Malaysia:12 Prescription (MAL-A)
Showing 12 of 12 registered brands
MAL Reg NoBrand Formulation NameStrength / DosageClassificationRegistration HolderAction
MAL26056026AZHEALOL TRANEXAMIC ACID (Tranexamic Acid Solution for Injection 500mg/5ml)500.00 mgPrescription (MAL-A)HEALOL PHARMACEUTICALS SDN. BHD.Compare →
MAL18056169AZHEAMIC-T (Tranexamic Acid Injection 100mg/mL)100mg/ml 0Prescription (MAL-A)UNIMED SDN. BHD.Compare →
MAL26076020AEHP-Tranexamic Acid 500mg Film-Coated Tablets500 mgPrescription (MAL-A)Hovid Pharmacy Sdn. Bhd.Compare →
MAL25116046AEHP-Tranexamic Acid Capsules 250mg500.00 mgPrescription (MAL-A)Hovid Pharmacy Sdn. Bhd.Compare →
MAL25116047AEHP-Tranexamic Acid Capsules 500mg500.00 mgPrescription (MAL-A)Hovid Pharmacy Sdn. Bhd.Compare →
MAL23066019AZMEDSAMIC 100MG/ML SOLUTION FOR INJECTION100 mg/mLPrescription (MAL-A)KOMEDIC SDN BHDCompare →
MAL11110007AZTRANEXAMIC ACID 500mg/5mL INJECTION Bioindustria L.I.M.500.00 mg 5.00 mlPrescription (MAL-A)MMS PHARMA (MALAYSIA) SDN. BHD.Compare →
MAL19890202ACZTRANSAMIN CAPSULE 250MG250MGPrescription (MAL-A)FIRST PHARMACEUTICAL SDN. BHD.Compare →
MAL12020014ACZTransamin Injection 250mg/5ml50 mg 1 mlPrescription (MAL-A)FIRST PHARMACEUTICAL SDN. BHD.Compare →
MAL19890204ACZTRANSAMIN S INJECTION 10%1000MGPrescription (MAL-A)FIRST PHARMACEUTICAL SDN. BHD.Compare →
MAL19991436AZTREN CAPSULE 250MG250MGPrescription (MAL-A)Y.S.P. INDUSTRIES (M) SDN. BHD.Compare →
MAL13075063AZYSP Tren Injection 100mg/ml500.0mg 5.0mlPrescription (MAL-A)Y.S.P. INDUSTRIES (M) SDN. BHD.Compare →

Generic Bioequivalence & Drug Substitution in Malaysia

Generic medications registered under NPRA contain the identical active pharmaceutical ingredient (API) in identical dosage strength and route of administration as the originator brand. NPRA requires rigorous bioequivalence (BE) studies demonstrating that generic drugs deliver the exact therapeutic effect. Always confirm with your doctor or community pharmacist before switching between prescription brands.